Delve into the world of hereditary cancer predisposition syndromes in this session designed to update clinicians on the ins and outs of cancer genetics. Together we learn how to identify patients at high risk, discuss clinical advances in genetic testing, and evaluate the utility of direct-to-consumer genetic testing. We critically analyze the availability and service delivery of genetic testing and share tools to help shape the landscape of your practice.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this continuing nursing education activity the learner will be able to recognize when urology patients need a referral for cancer genetic counsleing and have resources to faciliatate that referral.

Kidney stones are one of the most common benign urologic conditions, affecting nearly 1 in 11 individuals at some time in their lives. The epidemiology of kidney stones, management of the patient presenting with an acute stone, and surgical treatment options for patients with kidney stones are presented in this session.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this continuing nursing education activity, the learner will be able to describe the minimally invasive treatment options for patients with kidney stones and outline the considerations for treatment.

In 2014, the new term genitourinary syndrome of menopause (GSM) was introduced to encompass the symptoms associated with the loss of estrogen that occurs with menopause. These symptoms of atrophy affect the vulva, vagina, bladder and urethra. Patients can experience symptoms such as pain, sexual dysfunction, vaginal bleeding and recurrent urinary tract infections. In addition to vaginal estrogen, we review the non-estrogen medications and in-office procedures available to treat GSM.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this continuing nursing education activity the learner will be able to describe estrogen and non-estrogen therapies to treat genitourinary syndrome of menopause.

The management of BPH is reviewed using the AUA Guidelines. Included in this discussion are prevalence, signs and symptoms, appropriate H&P and diagnostic testing. Various treatments including watchful waiting, medical therapy, minimally invasive therapies and surgical procedures are discussed. A special emphasis is placed on postoperative care reviewing potential complications and interventions.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this continuing nursing education activity the learner will be able to discuss the pathophysiology, assessment, diagnosis and treatment of BPH.